Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Taylor Beth | VP- Finance & CFO | 6 | $147.4K | $0 | 2021-03-05 |
| Beattie John Gregory | Chief Operating Officer | 3 | $147.9K | $0 | 2021-03-01 |
| Leasure Robert Jr. | President and CEO | 20 | $348.1K | $0 | 2021-02-24 |
| Sagartz John E | Director, 10% Owner | 5 | $20.4K | $0 | 2020-12-02 |
| Baim Michael | VP Bioanalytical Services | 4 | $0 | $0 | 2020-12-02 |
| Pitchford William D | Chief HR Officer | 4 | $89.1K | $0 | 2020-12-02 |
| Downing Philip A | VP, Preclinical Srvcs. | 12 | $30.6K | $0 | 2020-12-02 |
| Neff R Matthew | Director | 16 | $247.9K | $0 | 2020-08-19 |
| Davis Gregory Cole | Director | 7 | $38.3K | $0 | 2020-04-01 |
| Johnson Richard Allen | Director | 6 | $105.2K | $0 | 2020-04-01 |
| Flynn Joseph Earl | Chief Commercial Officer | 2 | $0 | $0 | 2019-12-02 |
| Oakley Daniel Thomas | Chief Operating Officer | 12 | $116.4K | $0 | 2019-12-02 |
| Blumhoff Jill | VP, Finance & CFO | 12 | $990 | $0 | 2019-12-02 |
| Perrow Wendy | Director | 3 | $36.2K | $0 | 2019-09-10 |
| Sagartz Kimberly L | 10% Owner | 1 | $0 | $0 | 2019-04-16 |
| SW Chrysalis, LLC | 10% Owner | 1 | $0 | $0 | 2019-04-16 |
| KISSINGER PETER | 10% Owner | 1 | $17.4K | $0 | 2018-09-14 |
| Dougherty Connie Leigh | VP, Business Development | 5 | $11.8K | $0 | 2016-05-27 |
| Lemke Jacqueline M | President and CEO | 13 | $57.4K | $0 | 2016-02-29 |
| Devine John P | VP--Toxicology | 8 | $0 | $16.5K | 2014-08-25 |
| Potrzebowski Jeffrey | VP, Finance & CFO | 1 | $0 | $0 | 2014-06-09 |
| Bourdage James Sevall | VP, Bioanalytical Services | 1 | $0 | $0 | 2014-06-02 |
| Payne Lori | VP-Bioanalytical Services | 2 | $0 | $0 | 2013-01-16 |
| Sullivan A. Charlene | Director | 1 | $12.6K | $0 | 2012-08-17 |
| Landis John B. | Director | 2 | $37.8K | $0 | 2012-08-17 |
| Boulet Larry Steven | Director | 1 | $14.5K | $0 | 2012-08-17 |
| CRABB DAVID W | Director | 1 | $12.6K | $0 | 2012-08-17 |
| OMACHINSKI DAVID L | Director | 1 | $12.6K | $0 | 2012-08-17 |
| Chilton Anthony S | CEO and President | 1 | $0 | $0 | 2012-04-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Taylor Beth | VP- Finance & CFO | P Buy | 2021-03-05 | 2021-03-05 | 5,000 | $17.70 | $88.5K | 34,295 | SEC↗ |
| Beattie John Gregory | Chief Operating Officer | P Buy | 2021-03-01 | 2021-03-01 | 1,712 | $18.60 | $31.8K | 25,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2021-02-24 | 2021-02-24 | 5,000 | $14.42 | $72.1K | 5,000 | SEC↗ |
| Beattie John Gregory | Chief Operating Officer | P Buy | 2021-02-23 | 2021-02-25 | 8,288 | $14.00 | $116.0K | 23,288 | SEC↗ |
| Beattie John Gregory | Chief Operating Officer | A Award | 2021-02-15 | 2021-02-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | A Award | 2020-12-29 | 2020-12-30 | 40,000 | — | $0 | 226,549 | SEC↗ |
| Sagartz John E | Chief Strategy Officer | A Award | 2020-12-02 | 2020-12-04 | 9,653 | — | $0 | 643,885 | SEC↗ |
| Baim Michael | VP Bioanalytical Services | A Award | 2020-12-02 | 2020-12-04 | 6,938 | — | $0 | 14,656 | SEC↗ |
| Pitchford William D | Chief HR Officer | A Award | 2020-12-02 | 2020-12-04 | 7,541 | — | $0 | 39,541 | SEC↗ |
| Taylor Beth | VP- Finance & CFO | A Award | 2020-12-02 | 2020-12-04 | 5,995 | — | $0 | 29,295 | SEC↗ |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | A Award | 2020-12-02 | 2020-12-04 | 7,964 | — | $0 | 42,165 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-08-19 | 2020-08-19 | 5,000 | $4.75 | $23.8K | 60,350 | SEC↗ |
| Sagartz John E | Chief Strategy Officer | P Buy | 2020-08-19 | 2020-08-20 | 3,733 | $4.75 | $17.7K | 634,232 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2020-06-15 | 2020-06-16 | 2,884 | $5.20 | $15.0K | 186,549 | SEC↗ |
| Taylor Beth | VP- Finance & CFO | A Award | 2020-06-10 | 2020-06-11 | 10,000 | — | $0 | 23,300 | SEC↗ |
| Taylor Beth | VP- Finance & CFO | P Buy | 2020-05-21 | 2020-05-21 | 3,300 | $4.52 | $14.9K | 13,300 | SEC↗ |
| Pitchford William D | Chief HR Officer | P Buy | 2020-05-21 | 2020-05-22 | 10,000 | $4.47 | $44.7K | 32,000 | SEC↗ |
| Taylor Beth | VP- Finance & CFO | P Buy | 2020-05-20 | 2020-05-21 | 4,933 | $4.42 | $21.8K | 10,000 | SEC↗ |
| Taylor Beth | VP- Finance & CFO | P Buy | 2020-05-19 | 2020-05-21 | 5,067 | $4.38 | $22.2K | 5,067 | SEC↗ |
| Neff R Matthew | Director | A Award | 2020-04-01 | 2020-04-03 | 10,000 | — | $0 | 55,350 | SEC↗ |
| Johnson Richard Allen | Director | A Award | 2020-04-01 | 2020-04-03 | 10,000 | — | $0 | 40,000 | SEC↗ |
| Davis Gregory Cole | Director | A Award | 2020-04-01 | 2020-04-03 | 10,000 | — | $0 | 30,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2020-03-16 | 2020-03-17 | 5,700 | $3.49 | $19.9K | 183,665 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-03-13 | 2021-01-12 | 3,350 | $3.93 | $13.2K | 43,430 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-03-13 | 2020-03-16 | 3,350 | $3.93 | $13.2K | 45,350 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-03-12 | 2021-01-12 | 8,497 | $3.80 | $32.3K | 40,080 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-03-12 | 2020-03-16 | 12,000 | $3.80 | $45.6K | 42,000 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-02-20 | 2021-01-12 | 9,458 | $4.60 | $43.5K | 31,583 | SEC↗ |
| Johnson Richard Allen | Director | P Buy | 2020-02-20 | 2020-02-20 | 20,000 | $4.63 | $92.6K | 30,000 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2020-02-20 | 2020-02-21 | 9,458 | $4.60 | $43.5K | 30,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | A Award deriv | 2020-01-27 | 2020-01-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | A Award | 2020-01-27 | 2020-01-29 | 13,000 | — | $0 | 177,965 | SEC↗ |
| Baim Michael | VP Bioanalytical Services | A Award | 2019-12-02 | 2020-12-04 | 7,718 | — | $0 | 7,718 | SEC↗ |
| Baim Michael | VP Bioanalytical Services | A Award | 2019-12-02 | 2019-12-04 | 7,718 | — | $0 | 22,718 | SEC↗ |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | A Award | 2019-12-02 | 2019-12-04 | 8,436 | — | $0 | 34,201 | SEC↗ |
| Flynn Joseph Earl | Chief Commercial Officer | A Award | 2019-12-02 | 2019-12-04 | 2,564 | — | $0 | 127,514 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | A Award | 2019-12-02 | 2019-12-04 | 8,974 | — | $0 | 57,520 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | A Award | 2019-12-02 | 2019-12-04 | 7,000 | — | $0 | 8,811 | SEC↗ |
| Sagartz John E | Director, 10% Owner | A Award | 2019-12-02 | 2019-12-04 | 8,974 | — | $0 | 630,499 | SEC↗ |
| Pitchford William D | Chief HR Officer | P Buy | 2019-09-13 | 2019-09-16 | 12,000 | $3.70 | $44.4K | 22,000 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-09-13 | 2019-09-16 | 1,000 | $3.65 | $3.6K | 48,546 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-09-13 | 2019-09-16 | 26,846 | $3.72 | $99.9K | 164,965 | SEC↗ |
| Perrow Wendy | Director | P Buy | 2019-09-10 | 2019-09-11 | 10,000 | $3.62 | $36.2K | 10,000 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-09-06 | 2019-09-06 | 2,000 | $3.35 | $6.7K | 47,546 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-09-05 | 2019-09-06 | 10,500 | $3.45 | $36.2K | 45,546 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-09-04 | 2019-09-05 | 11,500 | $3.15 | $36.2K | 138,119 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-08-29 | 2019-09-03 | 5,000 | $2.69 | $13.4K | 36,046 | SEC↗ |
| Pitchford William D | Chief HR Officer | A Award | 2019-08-28 | 2019-09-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-08-23 | 2019-08-26 | 2,594 | $2.77 | $7.2K | 31,046 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-08-19 | 2019-08-20 | 16,000 | $2.19 | $35.0K | 126,619 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-06-14 | 2019-06-14 | 7,500 | $1.99 | $14.9K | 28,452 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-06-13 | 2019-06-14 | 5,000 | $1.97 | $9.8K | 110,619 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2019-06-13 | 2019-06-14 | 1,410 | $1.98 | $2.8K | 22,125 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-06-12 | 2019-06-14 | 4 | $1.94 | $8 | 105,619 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | P Buy | 2019-06-11 | 2019-06-13 | 500 | $1.98 | $990 | 1,811 | SEC↗ |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | P Buy | 2019-06-10 | 2019-06-11 | 5,000 | $1.96 | $9.8K | 25,765 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-06-07 | 2019-06-10 | 5,000 | $1.96 | $9.8K | 105,615 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-06-06 | 2019-06-10 | 1,000 | $1.95 | $1.9K | 100,615 | SEC↗ |
| Davis Gregory Cole | Director | P Buy | 2019-05-31 | 2019-05-31 | 5,000 | $2.00 | $10.0K | 20,000 | SEC↗ |
| Davis Gregory Cole | Director | P Buy | 2019-05-30 | 2019-05-31 | 5,000 | $1.96 | $9.8K | 15,000 | SEC↗ |
| Davis Gregory Cole | Director | P Buy | 2019-05-29 | 2019-05-31 | 5,000 | $1.99 | $9.9K | 10,000 | SEC↗ |
| Sagartz Kimberly L | 10% Owner | J Other | 2019-04-16 | 2019-04-24 | 632,475 | — | $0 | 632,475 | SEC↗ |
| SW Chrysalis, LLC | 10% Owner | J Other | 2019-04-16 | 2019-04-24 | 1,500,000 | — | $0 | 0 | SEC↗ |
| Flynn Joseph Earl | Chief Commercial Officer | J Other | 2019-04-16 | 2019-04-24 | 124,950 | — | $0 | 124,950 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-03-15 | 2019-03-19 | 1 | $1.90 | $2 | 20,952 | SEC↗ |
| Sagartz John E | Director, 10% Owner | P Buy | 2019-03-14 | 2019-03-14 | 1,400 | $1.94 | $2.7K | 3,900 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-03-12 | 2019-03-14 | 6,000 | $1.94 | $11.6K | 99,615 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2019-03-08 | 2019-03-11 | 5,715 | $1.75 | $10.0K | 20,715 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-03-08 | 2019-03-11 | 4,000 | $1.77 | $7.1K | 93,615 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-03-06 | 2019-03-07 | 10,000 | $1.75 | $17.5K | 20,951 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-03-01 | 2019-03-01 | 10,000 | $1.62 | $16.2K | 89,615 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-03-01 | 2019-03-05 | 125 | $1.54 | $193 | 10,951 | SEC↗ |
| Leasure Robert Jr. | President and CEO | P Buy | 2019-02-28 | 2019-03-01 | 8,900 | $1.51 | $13.4K | 79,615 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | P Buy | 2019-02-27 | 2019-02-28 | 10,826 | $1.53 | $16.6K | 10,826 | SEC↗ |
| Sagartz John E | Director, 10% Owner | L Small acq | 2019-02-19 | 2019-03-01 | 2,500 | $1.43 | $3.6K | 2,500 | SEC↗ |
| Oakley Daniel Thomas | Chief Operating Officer | A Award deriv | 2019-02-08 | 2019-02-12 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Baim Michael | VP Bioanalytical Services | A Award deriv | 2019-02-08 | 2019-02-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | A Award deriv | 2019-02-08 | 2019-02-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | A Award deriv | 2019-02-08 | 2019-02-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Perrow Wendy | Director | A Award deriv | 2019-02-08 | 2019-02-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Johnson Richard Allen | Director | A Award deriv | 2019-02-08 | 2019-02-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Davis Gregory Cole | Director | A Award deriv | 2019-02-08 | 2019-02-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Neff R Matthew | Director | A Award deriv | 2019-02-08 | 2019-02-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | A Award deriv | 2019-01-14 | 2019-01-16 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Leasure Robert Jr. | President and CEO | A Award | 2019-01-14 | 2019-01-16 | 10,000 | — | $0 | 70,715 | SEC↗ |
| Leasure Robert Jr. | President and CEO | A Award | 2019-01-14 | 2019-01-16 | 34,615 | — | $0 | 60,715 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2018-09-14 | 2018-09-18 | 2,500 | $1.66 | $4.2K | 15,000 | SEC↗ |
| KISSINGER PETER | 10% Owner | P Buy | 2018-09-14 | 2018-09-18 | 10,000 | $1.74 | $17.4K | 1,033,457 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | L Small acq | 2018-09-13 | 2018-09-18 | 450 | $1.62 | $729 | 1,311 | SEC↗ |
| Neff R Matthew | Director | L Small acq | 2018-09-12 | 2018-09-18 | 2,500 | $1.65 | $4.1K | 12,500 | SEC↗ |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | P Buy | 2018-09-11 | 2018-09-12 | 5,000 | $1.67 | $8.3K | 20,765 | SEC↗ |
| Downing Philip A | Sr. VP, Preclinical Srvcs. | P Buy | 2018-02-16 | 2018-02-20 | 5,000 | $1.46 | $7.3K | 15,765 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | A Award deriv | 2017-10-27 | 2017-10-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Downing Philip A | VP, Preclinical Srvcs. | A Award deriv | 2017-10-27 | 2017-10-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Johnson Richard Allen | Director | A Award deriv | 2017-10-27 | 2017-10-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Davis Gregory Cole | Director | A Award deriv | 2017-10-27 | 2017-10-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Perrow Wendy | Director | A Award deriv | 2017-10-27 | 2017-10-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Neff R Matthew | Director | A Award deriv | 2017-10-27 | 2017-10-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2017-09-08 | 2017-09-08 | 5,000 | $1.50 | $7.5K | 10,000 | SEC↗ |
| Neff R Matthew | Director | P Buy | 2017-08-18 | 2017-08-23 | 5,000 | $1.70 | $8.5K | 5,000 | SEC↗ |
| Davis Gregory Cole | Director | P Buy | 2017-08-18 | 2017-08-23 | 5,000 | $1.70 | $8.5K | 5,000 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | M Exercise deriv | 2017-03-15 | 2017-03-17 | 200 | — | $0 | 0 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | M Exercise deriv | 2017-03-15 | 2017-03-17 | 500 | — | $0 | 0 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | F Tax w/h | 2017-03-15 | 2017-03-17 | 422 | $1.66 | $701 | 861 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | M Exercise | 2017-03-15 | 2017-03-17 | 500 | $1.40 | $700 | 1,283 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | F Tax w/h | 2017-03-15 | 2017-03-17 | 1,217 | $1.66 | $2.0K | 783 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | M Exercise | 2017-03-15 | 2017-03-17 | 2,000 | $1.01 | $2.0K | 2,000 | SEC↗ |
| Downing Philip A | VP, Preclinical Srvcs. | M Exercise deriv | 2017-03-01 | 2017-03-15 | 10,000 | — | $0 | 0 | SEC↗ |
| Downing Philip A | VP, Preclinical Srvcs. | M Exercise | 2017-03-01 | 2017-03-15 | 10,000 | $1.01 | $10.1K | 17,000 | SEC↗ |
| Downing Philip A | VP, Preclinical Srvcs. | F Tax w/h | 2017-03-01 | 2017-03-15 | 6,235 | $1.62 | $10.1K | 10,765 | SEC↗ |
| Dougherty Connie Leigh | VP, Business Development | P Buy | 2016-05-27 | 2016-05-27 | 423 | $0.92 | $389 | 9,074 | SEC↗ |
| Dougherty Connie Leigh | VP, Business Development | P Buy | 2016-05-23 | 2016-05-25 | 96 | $0.92 | $88 | 8,651 | SEC↗ |
| Dougherty Connie Leigh | VP, Business Development | P Buy | 2016-05-19 | 2016-05-23 | 1,655 | $0.92 | $1.5K | 8,555 | SEC↗ |
| Blumhoff Jill | VP, Finance & CFO | A Award deriv | 2016-05-13 | 2016-05-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Lemke Jacqueline M | President and CEO | P Buy | 2016-02-29 | 2016-03-02 | 4,000 | $1.19 | $4.8K | 60,685 | SEC↗ |
| Lemke Jacqueline M | President and CEO | P Buy | 2016-02-29 | 2016-03-02 | 6,000 | $1.17 | $7.0K | 9,000 | SEC↗ |
| Downing Philip A | VP, Preclinical Srvcs. | P Buy | 2015-09-14 | 2015-09-16 | 3,000 | $1.73 | $5.2K | 7,000 | SEC↗ |
| Dougherty Connie Leigh | VP, Business Development | P Buy | 2015-08-21 | 2015-08-25 | 6,900 | $1.42 | $9.8K | 6,900 | SEC↗ |
| Lemke Jacqueline M | President and CEO | M Exercise deriv | 2015-06-18 | 2015-06-22 | 125,000 | — | $0 | 0 | SEC↗ |
| Lemke Jacqueline M | President and CEO | M Exercise deriv | 2015-06-18 | 2015-06-22 | 500 | — | $0 | 0 | SEC↗ |
| Lemke Jacqueline M | President and CEO | M Exercise | 2015-06-18 | 2015-06-22 | 125,000 | $1.38 | $172.5K | 153,000 | SEC↗ |
| Lemke Jacqueline M | President and CEO | M Exercise | 2015-06-18 | 2015-06-22 | 500 | $1.40 | $700 | 153,500 | SEC↗ |
| Lemke Jacqueline M | President and CEO | F Tax w/h | 2015-06-18 | 2015-06-22 | 96,815 | $2.12 | $205.2K | 56,685 | SEC↗ |
| Downing Philip A | VP, Preclinical Srvcs. | A Award deriv | 2015-03-13 | 2015-03-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Lemke Jacqueline M | President and CEO | P Buy | 2015-02-27 | 2015-03-03 | 7,000 | $2.04 | $14.3K | 28,000 | SEC↗ |
| Lemke Jacqueline M | President and CEO | P Buy | 2015-02-27 | 2015-03-03 | 3,000 | $2.04 | $6.1K | 3,000 | SEC↗ |
| Dougherty Connie Leigh | VP, Business Development | A Award deriv | 2014-09-15 | 2014-09-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Devine John P | VP--Toxicology | M Exercise deriv | 2014-08-25 | 2014-08-26 | 2,500 | — | $0 | 2,500 | SEC↗ |
| Devine John P | VP--Toxicology | M Exercise | 2014-08-25 | 2014-08-26 | 2,500 | $1.01 | $2.5K | 2,500 | SEC↗ |
| Devine John P | VP--Toxicology | S Sale | 2014-06-13 | 2014-06-17 | 3,130 | $2.64 | $8.3K | 0 | SEC↗ |
| Devine John P | VP--Toxicology | S Sale | 2014-06-13 | 2014-06-19 | 3,130 | $2.64 | $8.3K | 0 | SEC↗ |
| Potrzebowski Jeffrey | VP, Finance & CFO | A Award deriv | 2014-06-09 | 2014-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Bourdage James Sevall | VP, Bioanalytical Services | A Award deriv | 2014-06-02 | 2014-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Devine John P | VP--Toxicology | M Exercise deriv | 2014-03-03 | 2014-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Devine John P | VP--Toxicology | M Exercise | 2014-03-03 | 2014-06-17 | 5,000 | $1.01 | $5.0K | 5,000 | SEC↗ |
| Devine John P | VP--Toxicology | F Tax w/h | 2014-03-03 | 2014-06-17 | 1,870 | $2.70 | $5.0K | 3,130 | SEC↗ |
| Payne Lori | VP-Bioanalytical Services | A Award deriv | 2013-01-16 | 2013-01-17 | 500 | — | $0 | 500 | SEC↗ |
| Devine John P | VP--Toxicology | A Award deriv | 2013-01-16 | 2013-01-17 | 500 | — | $0 | 500 | SEC↗ |
| Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP F | A Award deriv | 2013-01-16 | 2013-01-17 | 500 | — | $0 | 500 | SEC↗ |
| Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP F | A Award deriv | 2012-10-15 | 2012-10-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OMACHINSKI DAVID L | Director | P Buy | 2012-08-17 | 2012-08-20 | 10,000 | $1.26 | $12.6K | 20,000 | SEC↗ |
| Boulet Larry Steven | Director | P Buy | 2012-08-17 | 2012-08-20 | 11,500 | $1.26 | $14.5K | 15,000 | SEC↗ |
| Landis John B. | Director | P Buy | 2012-08-17 | 2012-08-20 | 30,000 | $1.26 | $37.8K | 30,000 | SEC↗ |
| CRABB DAVID W | Director | P Buy | 2012-08-17 | 2012-08-20 | 10,000 | $1.26 | $12.6K | 11,300 | SEC↗ |
| Lemke Jacqueline M | Intrm Pres & CEO, CFO & VP F | P Buy | 2012-08-17 | 2012-08-20 | 20,000 | $1.26 | $25.2K | 21,000 | SEC↗ |
| Sullivan A. Charlene | Director | P Buy | 2012-08-17 | 2012-08-20 | 10,000 | $1.26 | $12.6K | 10,000 | SEC↗ |
| Johnson Richard Allen | Director | P Buy | 2012-08-17 | 2012-08-20 | 10,000 | $1.26 | $12.6K | 10,000 | SEC↗ |
| Landis John B. | Director | A Award deriv | 2012-07-05 | 2012-07-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Johnson Richard Allen | Director | A Award deriv | 2012-07-05 | 2012-07-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Lemke Jacqueline M | CFO & Vice President--Financ | A Award deriv | 2012-04-09 | 2012-04-11 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Payne Lori | VP Bioanalytical Services | A Award deriv | 2012-04-09 | 2012-04-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Chilton Anthony S | CEO and President | A Award deriv | 2012-04-09 | 2012-04-11 | 25,000 | — | $0 | 25,000 | SEC↗ |